XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income (Loss)
Balance beginning of period (in shares) at Dec. 31, 2020   71,998,654      
Balance beginning of period at Dec. 31, 2020 $ 1,738,863 $ 72 $ 5,566,902 $ (3,815,662) $ (12,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (100)     (100)  
Unrealized gain (loss) on derivatives 1,893       1,893
Reclassification to (from) interest expense net 1,017       1,017
Reclassification to (from) equity in earnings of unconsolidated entities 31       31
Distributions declared (14,065)     (14,065)  
Stock-based compensation, net 1,383   1,383    
Balance end of period (in shares) at Mar. 31, 2021   71,998,654      
Balance end of period at Mar. 31, 2021 1,729,022 $ 72 5,568,285 (3,829,827) (9,508)
Balance beginning of period (in shares) at Dec. 31, 2020   71,998,654      
Balance beginning of period at Dec. 31, 2020 1,738,863 $ 72 5,566,902 (3,815,662) (12,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 5,391        
Unrealized gain (loss) on derivatives 1,560        
Balance end of period (in shares) at Sep. 30, 2021   71,261,403      
Balance end of period at Sep. 30, 2021 1,694,816 $ 71 5,554,596 (3,852,190) (7,661)
Balance beginning of period (in shares) at Mar. 31, 2021   71,998,654      
Balance beginning of period at Mar. 31, 2021 1,729,022 $ 72 5,568,285 (3,829,827) (9,508)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,499     1,499  
Unrealized gain (loss) on derivatives (138)       (138)
Reclassification to (from) interest expense net 1,045       1,045
Reclassification to (from) equity in earnings of unconsolidated entities 33       33
Distributions declared (13,921)     (13,921)  
Stock-based compensation, net (in shares)   18,392      
Stock-based compensation, net 1,863   1,863    
Repurchase of common stock under share repurchase plan, net (in shares)   (755,643)      
Repurchase of common stock under share repurchase plan, net (16,679) $ (1) (16,678)    
Balance end of period (in shares) at Jun. 30, 2021   71,261,403      
Balance end of period at Jun. 30, 2021 1,702,724 $ 71 5,553,470 (3,842,249) (8,568)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,992     3,992  
Unrealized gain (loss) on derivatives (195)       (195)
Reclassification to (from) interest expense net 1,067       1,067
Reclassification to (from) equity in earnings of unconsolidated entities 35       35
Distributions declared (13,933)     (13,933)  
Stock-based compensation, net 1,126   1,126    
Balance end of period (in shares) at Sep. 30, 2021   71,261,403      
Balance end of period at Sep. 30, 2021 1,694,816 $ 71 5,554,596 (3,852,190) (7,661)
Balance beginning of period (in shares) at Dec. 31, 2021   67,344,374      
Balance beginning of period at Dec. 31, 2021 1,571,552 $ 67 5,452,550 (3,876,743) (4,322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 9,501     9,501  
Unrealized gain (loss) on derivatives 15,406       15,406
Reclassification to (from) interest expense net 1,003       1,003
Reclassification to (from) equity in earnings of unconsolidated entities 22       22
Distributions declared (13,828)     (13,828)  
Stock-based compensation, net (in shares)   44,329      
Stock-based compensation, net 550   550    
Balance end of period (in shares) at Mar. 31, 2022   67,388,703      
Balance end of period at Mar. 31, 2022 1,584,206 $ 67 5,453,100 (3,881,070) 12,109
Balance beginning of period (in shares) at Dec. 31, 2021   67,344,374      
Balance beginning of period at Dec. 31, 2021 1,571,552 $ 67 5,452,550 (3,876,743) (4,322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 52,358        
Unrealized gain (loss) on derivatives 32,912        
Balance end of period (in shares) at Sep. 30, 2022   67,427,571      
Balance end of period at Sep. 30, 2022 1,618,747 $ 67 5,455,228 (3,865,885) 29,337
Balance beginning of period (in shares) at Mar. 31, 2022   67,388,703      
Balance beginning of period at Mar. 31, 2022 1,584,206 $ 67 5,453,100 (3,881,070) 12,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 41,921     41,921  
Unrealized gain (loss) on derivatives 5,514       5,514
Reclassification to (from) interest expense net 547       547
Reclassification to (from) equity in earnings of unconsolidated entities (55)       (55)
Distributions declared (13,836)     (13,836)  
Stock-based compensation, net (in shares)   38,868      
Stock-based compensation, net 1,192   1,192    
Balance end of period (in shares) at Jun. 30, 2022   67,427,571      
Balance end of period at Jun. 30, 2022 1,619,489 $ 67 5,454,292 (3,852,985) 18,115
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 936     936  
Unrealized gain (loss) on derivatives 11,992       11,992
Reclassification to (from) interest expense net (559)       (559)
Reclassification to (from) equity in earnings of unconsolidated entities (211)       (211)
Distributions declared (13,836)     (13,836)  
Stock-based compensation, net (in shares)   0      
Stock-based compensation, net 936   936    
Balance end of period (in shares) at Sep. 30, 2022   67,427,571      
Balance end of period at Sep. 30, 2022 $ 1,618,747 $ 67 $ 5,455,228 $ (3,865,885) $ 29,337